Qingdao Vland Biotech INC. (SHA:603739)

SHA:603739 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,305	1,282	1,177	1,135	1,110	936.23
Other Revenue	38.97	38.97	21.48	28.42	40.48	24.02
Revenue	1,344	1,321	1,199	1,163	1,151	960.25
Revenue Growth (YoY)	7.27%	10.16%	3.07%	1.07%	19.85%	13.40%
Cost of Revenue	741.72	728.42	648.46	662.86	620.4	495.66
Gross Profit	602.46	592.34	550.44	500.3	530.43	464.59
Selling, General & Admin	349.64	343.98	314.46	297.58	285	257.92
Research & Development	120	118.22	110.68	102.4	100.94	79.91
Other Operating Expenses	18.15	11.79	9.19	8.78	8.96	8.67
Operating Expenses	487.62	477.91	447.32	420.62	400.69	352.79
Operating Income	114.84	114.44	103.12	79.68	129.74	111.79
Interest Expense	-22.49	-21.88	-15.22	-7.17	-2.12	-1.78
Interest & Investment Income	-	1.53	8	3.93	7.91	6.09
Currency Exchange Gain (Loss)	0.47	0.47	0.58	3.21	-1.18	-2.3
Other Non Operating Income (Expenses)	-3.38	-2.97	-1.62	-8.46	-1.88	-0.45
EBT Excluding Unusual Items	89.44	91.58	94.87	71.18	132.46	113.35
Gain (Loss) on Sale of Investments	7.04	7.08	9.22	0.21	0.43	0.45
Gain (Loss) on Sale of Assets	-0.39	0.13	-0.25	0.29	-0.05	0.14
Asset Writedown	0.09	-0.07	-2.75	-	-	-0.68
Other Unusual Items	28.98	24.73	21.41	30.51	38.56	26.88
Pretax Income	125.16	123.44	122.5	102.19	171.4	140.15
Income Tax Expense	33.57	31.27	19.64	16.78	21.31	17.84
Earnings From Continuing Operations	91.6	92.17	102.86	85.41	150.1	122.3
Minority Interest in Earnings	-32.1	-29.53	-22.15	-15.57	-17.52	-13.33
Net Income	59.49	62.64	80.71	69.84	132.57	108.98
Net Income to Common	59.49	62.64	80.71	69.84	132.57	108.98
Net Income Growth	-28.21%	-22.39%	15.56%	-47.32%	21.65%	40.16%
Shares Outstanding (Basic)	247	251	252	249	246	227
Shares Outstanding (Diluted)	247	251	252	259	246	227
Shares Change (YoY)	-1.21%	-0.66%	-2.50%	5.36%	8.14%	6.37%
EPS (Basic)	0.24	0.25	0.32	0.28	0.54	0.48
EPS (Diluted)	0.24	0.25	0.32	0.27	0.54	0.48
EPS Growth	-27.33%	-21.88%	18.52%	-50.00%	12.50%	31.76%
Free Cash Flow	87.88	90.69	-62.05	-246.72	-404.06	-38.83
Free Cash Flow Per Share	0.36	0.36	-0.25	-0.95	-1.65	-0.17
Dividend Per Share	0.100	0.100	0.100	0.100	0.160	0.143
Dividend Growth	-	-	-	-37.50%	11.97%	-
Gross Margin	44.82%	44.85%	45.91%	43.01%	46.09%	48.38%
Operating Margin	8.54%	8.66%	8.60%	6.85%	11.27%	11.64%
Profit Margin	4.43%	4.74%	6.73%	6.00%	11.52%	11.35%
Free Cash Flow Margin	6.54%	6.87%	-5.18%	-21.21%	-35.11%	-4.04%
EBITDA	234.41	224.85	176.92	145.39	181.44	154.66
EBITDA Margin	17.44%	17.02%	14.76%	12.50%	15.77%	16.11%
D&A For EBITDA	119.57	110.41	73.79	65.71	51.7	42.87
EBIT	114.84	114.44	103.12	79.68	129.74	111.79
EBIT Margin	8.54%	8.66%	8.60%	6.85%	11.27%	11.64%
Effective Tax Rate	26.82%	25.33%	16.03%	16.42%	12.43%	12.73%
Revenue as Reported	1,344	1,321	1,199	1,163	1,151	960.25
Advertising Expenses	-	7.09	6.59	5.02	5.67	5.43

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.